3-Tolylboronic acid → HCID 23725693, compound
Reaction equation
[NH:1]1[CH:5]=[C:4]([C:6]2[C:7]([C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=3)=[N:8][O:9][C:10]=2[CH3:11])[N:3]=[CH:2]1.[CH3:18][C:19]1[CH:20]=[C:21](B(O)O)[CH:22]=[CH:23][CH:24]=1>>[CH3:11][C:10]1[O:9][N:8]=[C:7]([C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=2)[C:6]=1[C:4]1[N:3]=[CH:2][N:1]([C:23]2[CH:24]=[C:19]([CH3:18])[CH:20]=[CH:21][CH:22]=2)[CH:5]=1Participants
3
Procedure
As described for Example 3, 4-(1H-imidazol-4-yl)-5-methyl-3-phenyl-isoxazole (112.6 mg, 0.5 mmol) was converted, using 3-methylphenylboronic acid instead of 4-fluorophenylboronic acid, to the title compound (16 mg, 10%) which was obtained as a white solid. MS (ESI): m/e=315.0 [M+H]+.
Sources & evidence
- ORD record
- ord-aa61118a46244be0ba24a6ae4ea6fc77
- Source dataset
- uspto-grants-2008_08
- Patent number
- US07414061B2
Reaction notes
Loading…